Capital World Investors - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital World Investors ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$57,407,000
+15.5%
293,355
+0.3%
0.01%
+8.3%
Q2 2020$49,717,000
+47.4%
292,591
+0.1%
0.01%
+20.0%
Q1 2020$33,737,000
+143.9%
292,402
-21.4%
0.01%
+150.0%
Q3 2014$13,831,000
-2.8%
372,0000.0%0.00%0.0%
Q2 2014$14,229,000
-16.0%
372,0000.0%0.00%
-20.0%
Q1 2014$16,948,000
+14.2%
372,0000.0%0.01%
+25.0%
Q4 2013$14,839,000
-9.0%
372,0000.0%0.00%
-20.0%
Q3 2013$16,305,000
+39.3%
372,0000.0%0.01%
+25.0%
Q2 2013$11,703,000372,0000.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders